RT Journal Article
SR Electronic
T1 Network analysis of cross-income-level collaboration on non-communicable disease: the example of multiple myeloma in Sub-Saharan Africa
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.10.24.24316045
DO 10.1101/2024.10.24.24316045
A1 Yang, Kaiyi
A1 Benkwitz-Bedford, Sam
A1 Cazier, Jean-Baptiste
A1 Spill, Fabian
YR 2024
UL http://medrxiv.org/content/early/2024/10/25/2024.10.24.24316045.abstract
AB Cross-income-level collaboration (CILC) is crucial for developing global health approaches that benefit low- and middle-income countries (LMICs). Multiple myeloma (MM) is a representative example of a complex, understudied disease in sub-Saharan Africa (SSA). Based on publications, we developed a network analysis tool to assess scientific collaborations. Here, we present findings from a systematic analysis of publications retrieved from PubMed between January 2002 and June 2022. We evaluated individual institutional contributions and collaboration patterns using undirected weighted networks. Our findings reveal that intraincome-level collaborations dominate MM research in SSA, with high-income countries (HICs) primarily engaging with a few local institutions, mainly in South Africa and Nigeria. Increasing CILC is essential to advance research in this area. Our analysis tool provides insights into the collaboration strength, highlights gaps in the field and identifies leading institutions, ultimately aiming to support the development of more effective international collaboration and research strategies in MM.Competing Interest StatementThe authors have declared no competing interest.Funding StatementF.S. was supported by a UKRI Future Leaders Fellowship, grant no. (MR/T043571/1).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors https://gitlab.bham.ac.uk/spillf-systems-mechanobiology-health-disease/collaboration-network-multiple-myeloma AbbreviationsMMmultiple myelomaSSASub-saharan AfricaLMICLow-and-middle-income countryHICHigh-income countryCILCcross-income-level collaboration